Literature DB >> 20499198

Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis.

Alan S Rosman1, Mark A Korsten.   

Abstract

OBJECTIVES: There is controversy regarding the sensitivity of fecal occult blood tests (FOBT) for detecting colorectal cancer. Many of the published studies failed to correct for verification bias which may have increased the sensitivity.
METHODS: A meta-analysis of published studies evaluating the sensitivity and specificity of chemical-based FOBT for colorectal cancer was performed. Studies were included if both cancer and control subjects underwent confirmatory testing. We also included studies that attempted to correct for verification bias by either performing colonoscopy on all subjects regardless of the FOBT result or by using longitudinal follow-up. We then compared the sensitivity, specificity, and other diagnostic characteristics of the studies that attempted to correct for verification (n=10) vs. those that did not correct for this bias (n=19).
RESULTS: The pooled sensitivity of guaiac-based FOBT for colorectal cancer of studies without verification bias was significantly lower than those studies with this bias [0.36 (95% CI 0.25-0.47) vs. 0.70 (95% CI 0.60-0.80), p=0.001]. The pooled specificity of the studies without verification bias was higher [0.96 (95% CI 0.94-0.97) vs. 0.88 (95% CI 0.84-0.91), p<0.005]. There was no significant difference in the area under the summary receiver operating characteristic curves. More sensitive chemical-based FOBT methods (e.g., Hemoccult® SENSA®) had a higher sensitivity but a lower specificity than standard guaiac methods.
CONCLUSIONS: The sensitivity of guaiac-based FOBT for colorectal cancer has been overestimated as a result of verification bias. This test may not be sensitive enough to serve as an effective screening option for colorectal cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20499198      PMCID: PMC2947648          DOI: 10.1007/s11606-010-1375-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  74 in total

1.  Biases in the assessment of diagnostic tests.

Authors:  C B Begg
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

Review 2.  Noninvasive testing for colorectal cancer: a review.

Authors:  Daniel L Ouyang; Joseph J Chen; Robert H Getzenberg; Robert E Schoen
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

3.  Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.

Authors:  L E Moses; D Shapiro; B Littenberg
Journal:  Stat Med       Date:  1993-07-30       Impact factor: 2.373

Review 4.  Fecal occult blood testing: clinical value and limitations.

Authors:  J B Simon
Journal:  Gastroenterologist       Date:  1998-03

5.  Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.

Authors:  Konstanze Lenhard; Guido T Bommer; Silke Asutay; Rolf Schauer; Thomas Brabletz; Burkhard Göke; Rolf Lamerz; Frank T Kolligs
Journal:  Clin Gastroenterol Hepatol       Date:  2005-02       Impact factor: 11.382

6.  Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Authors:  James E Allison; Lori C Sakoda; Theodore R Levin; Jo P Tucker; Irene S Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M Palitz; Wei K Zhao; J Sanford Schwartz; David F Ransohoff; Joseph V Selby
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

7.  Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Authors:  David A Ahlquist; Daniel J Sargent; Charles L Loprinzi; Theodore R Levin; Douglas K Rex; Dennis J Ahnen; Kandice Knigge; M Peter Lance; Lawrence J Burgart; Stanley R Hamilton; James E Allison; Michael J Lawson; Mary E Devens; Jonathan J Harrington; Shauna L Hillman
Journal:  Ann Intern Med       Date:  2008-10-07       Impact factor: 25.391

8.  A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.

Authors:  B C-Y Wong; W M Wong; K L Cheung; T S M Tong; P Rozen; G P Young; K W Chu; J Ho; W L Law; H M Tung; K C Lai; W H C Hu; C K Chan; S K Lam
Journal:  Aliment Pharmacol Ther       Date:  2003-11-01       Impact factor: 8.171

9.  An assessment of an immunochemical test for human haemoglobin in the detection of colonic polyps.

Authors:  J A Williams; R Hunter; M E Coles; D W Thomas; T W Huber
Journal:  Aust N Z J Surg       Date:  1985-10

10.  Diagnostic validity of fecal occult blood tests for detecting gastroenterological cancers.

Authors:  R Murakami; T Otani; K Nakanishi; Y Fudemoto; H Ishikawa; T Hiyama; H Tsukuma; I Fujimoto; N Miki; A Oshima
Journal:  Jpn J Cancer Res       Date:  1992-02
View more
  11 in total

1.  A study of the frequency of methylation of gene promoter regions in colorectal cancer in the Taiwanese population.

Authors:  Chang-Chieh Wu; Jen-Chun Kuan; Chih-Hsiung Hsu; Tzu-An Chen; Chien-An Sun; Tsan Yang; Shinn-Long Lin; Yu-Ching Chou
Journal:  J Genet       Date:  2013-04       Impact factor: 1.166

2.  One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Authors:  Germaine Wong; Richard L Hope; Kirsten Howard; Jeremy R Chapman; Antoni Castells; Simon D Roger; Michael J Bourke; Petra Macaskill; Robin Turner; Gabrielle Williams; Wai Hon Lim; Charmaine E Lok; Fritz Diekmann; Nicholas B Cross; Shaundeep Sen; Richard D M Allen; Steven J Chadban; Carol A Pollock; Allison Tong; Armando Teixeira-Pinto; Jean Y H Yang; Narelle Williams; Eric Hoi Kit Au; Anh Kieu; Laura James; Jonathan C Craig
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

3.  Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.

Authors:  Jessica Chubak; Andrea N Burnett-Hartman; William E Barlow; Douglas A Corley; Jennifer M Croswell; Christine Neslund-Dudas; Anil Vachani; Michelle I Silver; Jasmin A Tiro; Aruna Kamineni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

4.  Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.

Authors:  Kevin Selby; Christopher D Jensen; Jeffrey K Lee; Chyke A Doubeni; Joanne E Schottinger; Wei K Zhao; Jessica Chubak; Ethan Halm; Nirupa R Ghai; Richard Contreras; Celette Skinner; Aruna Kamineni; Theodore R Levin; Douglas A Corley
Journal:  Ann Intern Med       Date:  2018-09-18       Impact factor: 25.391

5.  Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.

Authors:  Kevin Selby; Emma H Levine; Cecilia Doan; Anton Gies; Hermann Brenner; Charles Quesenberry; Jeffrey K Lee; Douglas A Corley
Journal:  Gastroenterology       Date:  2019-08-22       Impact factor: 22.682

Review 6.  Fecal immunochemical tests in combination with blood tests for colorectal cancer and advanced adenoma detection-systematic review.

Authors:  Tobias Niedermaier; Korbinian Weigl; Michael Hoffmeister; Hermann Brenner
Journal:  United European Gastroenterol J       Date:  2017-10-09       Impact factor: 4.623

7.  Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test.

Authors:  Renée M Ned; Stephanie Melillo; Michael Marrone
Journal:  PLoS Curr       Date:  2011-03-22

8.  Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.

Authors:  Michael G Collins; Edward Teo; Stephen R Cole; Choy-Yoke Chan; Stephen P McDonald; Graeme R Russ; Graeme P Young; Peter A Bampton; P Toby Coates
Journal:  BMJ       Date:  2012-07-25

9.  Estimating the Impact of Verification Bias on Celiac Disease Testing.

Authors:  Isabel A Hujoel; Claire L Jansson-Knodell; Philippe P Hujoel; Margaux L A Hujoel; Rok Seon Choung; Joseph A Murray; Alberto Rubio-Tapia
Journal:  J Clin Gastroenterol       Date:  2021-04-01       Impact factor: 3.174

10.  Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.

Authors:  Shirong Yan; Zijing Liu; Shuang Yu; Yixi Bao
Journal:  Med Sci Monit       Date:  2016-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.